| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,837 | 1,867 | 1,923 | 1,988 | | Cost of Revenue | 1,320 | 1,341 | 1,272 | 1,340 | | | Gross Profit | 517 | 526 | 651 | 648 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 779 | 750 | 864 | 686 | | Non Recurring | (3) | 1,120 |
-
|
-
| | Others | 247 | 244 | 260 | 276 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (507) | (1,588) | (473) | (314) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4 | 4 | 5 | 12 | | Earnings Before Interest And Taxes | (503) | (1,578) | (468) | (302) | | Interest Expense | 19 | 14 | 24 | 23 | | Income Before Tax | (522) | (1,592) | (492) | (325) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 0 | 6 | (0) | 0 | | | | Net Income From Continuing Ops | (522) | (1,592) | (492) | (325) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (522) | (1,592) | (492) | (325) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($522) | ($1,592) | ($492) | ($325) |
|
0.11% Nasdaq 
0.01%
Income Statement
